Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 2 Prostatic Neoplasms 2 Monoclonal Gammopathy of Undetermined Significance 2 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neurofibromatosis 1 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Gastritis, Atrophic 1

Interventions

AZD 6244 7 trametinib 4 mirdametinib 2 fludarabine 2 Inhalation 2 Acetylcysteine 2 thymoglobulin 1 talimogene laherparepvec 1 omipalisib 1 lorlatinib 1 fludarabine phosphate 1 encorafenib 1 dabrafenib 1 binimetinib 1 abemaciclib 1 Vincristine 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Radiation 1 N-monoacetylcystine 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Levetiracetam 1 Lasers, Solid-State 1 Lasers 1 Injections 1 Deoxycholic Acid 1 Cytarabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Curcumin × 90 days × Clear all

NCT05363267 2026-06-01

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡